Alimera Sciences, Inc. - Common Stock (ALIM)
5.5400
0.00 (0.00%)
Alimera Sciences Inc is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapies for retinal diseases
The company primarily concentrates on addressing the needs of patients suffering from chronic eye conditions, particularly those related to diabetic macular edema. Alimera aims to enhance visual function and improve the quality of life for individuals with these debilitating conditions through its advanced drug formulations and delivery systems. By leveraging its expertise in ocular therapeutics, the company is committed to advancing care in the field of ophthalmology.
Frequently Asked Questions
Is Alimera Sciences, Inc. - Common Stock publicly traded?
Yes, Alimera Sciences, Inc. - Common Stock is publicly traded.
What exchange does Alimera Sciences, Inc. - Common Stock trade on?
Alimera Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alimera Sciences, Inc. - Common Stock?
The ticker symbol for Alimera Sciences, Inc. - Common Stock is ALIM on the Nasdaq Stock Market
What is the current price of Alimera Sciences, Inc. - Common Stock?
The current price of Alimera Sciences, Inc. - Common Stock is 5.540
When was Alimera Sciences, Inc. - Common Stock last traded?
The last trade of Alimera Sciences, Inc. - Common Stock was at 4:00 pm EDT on September 13th, 2024
What is the market capitalization of Alimera Sciences, Inc. - Common Stock?
The market capitalization of Alimera Sciences, Inc. - Common Stock is 290.23M
How many shares of Alimera Sciences, Inc. - Common Stock are outstanding?
Alimera Sciences, Inc. - Common Stock has 52.39M shares outstanding.